Bas Trietsch Discusses Successes so Far Using Organ on a Chip Technology for Bio/Pharmaceuticals (INTERPHEX 2023)

Article

Bas Trietsch, chief technology officer, MIMETAS, discusses the successes he's encountered so far using organ on a chip technology in bio/pharmaceutical research.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Bas Trietsch, chief technology officer, MIMETAS, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, discusses the successes his company has encountered so far using organ on a chip technology in bio/pharmaceutical research.

      For more INTERPHEX 2023 video content, check this page for updates.

      Related Content